ACLX
ACLX
NASDAQ · Biotechnology

Arcellx Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$115.07
+0.04 (+0.03%)
As of May 8, 9:56 PM ET ·
Analyst Consensus
Hold
23
Analysts
High
Coverage
Buy 0 0%
Hold 20 87%
Sell 3 13%
Price Target
Analyst Price Target -15.7% upside
Low Target $73.10
Average Target $96.95
High Target $131.09
Current Price $115.07
Current
$115.07
Target
$96.95
$73.10 $96.95 avg $131.09
Scenario Analysis
Bear Case
$73.10
-36.5%
Low target
Base Case
$96.95
-15.7%
Avg target
Bull Case
$131.09
+13.9%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$115.13
-0.1% from high
52-Week Low
$47.86
+140.4% from low
50-Day SMA
$67.56
+70.3% vs SMA
200-Day SMA
$71.93
+60.0% vs SMA
RSI (14)
44.8
Neutral
Target vs 52W High
$96.95
-15.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%